Phase 1: User Testing & Diagnosing the determinants
(September 2024- September 2025 )
Understanding the challenges and solutions to healthcare professionals routinely using the IMAB-Qi
Phase 2: co-design an implemation package
(September 2025- December 2025 )
Designing a package to support healthcare professionals to routinely use the IMAB-Qi
Phase 3: Feasibility Study
Early 2026
Testing whether the IMAB-Qi can be routinely used by healthcare professionals and whether trial data can be collected
Phase 4: Definitive trial
May 2027
Evaluating the safety, acceptability and effectiveness of the IMAB-Qi (definitive trial)
Phase 5: Economic evaluation
Jan 2028
Evaluating whether the IMAB-Qi will be good value for money for the NHS in the long-term
